Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

Umaña, Pablo, Jean–Mairet, Joël, Moudry, Radmila, Amstutz, Hanspeter, Bailey, James E.·1999·Nature Biotechnology

Cited by (764)

Items 301–400 of 764

  1. FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality
    Salina Louie, Benjamin Haley, Brett Marshall, Amy J. Heidersbach, Mandy Yim, Martina Brozynski, Danming Tang, Cynthia Lam, Bronislawa Petryniak, David Shaw et al. · 2016 · Biotechnology and Bioengineering
  2. Antibody-Based Cancer Therapy
    Djoke Hendriks, Goda Choi, Marco de Bruyn, Valerie R. Wiersma, Edwin Bremer · 2017 · International review of cytology
  3. Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
    Ziqing Chen, Ying Yang, Lisa L. Liu, Andreas Lundqvist · 2019 · Cancers
  4. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans
    Pamela Stanley · 2004 · Glycobiology
  5. The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy
    Sara Trzos, Paweł Link‐Lenczowski, Ewa Pocheć · 2023 · Frontiers in Immunology
  6. A human anti‐D monoclonal antibody selected for enhanced FcγRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti‐D antibodies
    Roland Béliard, Tony Waegemans, Dominique Notelet, Léna Massad, F. Dhainaut, Christophe de Romeuf, Eric Guémas, Wouter Haazen, Dominique Bourel, Jean‐Luc Teillaud et al. · 2008 · British Journal of Haematology
  7. Controlled release of therapeutic antibody formats
    Daniel Schweizer, Tim Serno, Achim M. Göpferich · 2014 · European Journal of Pharmaceutics and Biopharmaceutics
  8. Human cell lines for the production of recombinant proteins: on the horizon
    Lukas Fliedl, Johannes Grillari, Regina Grillari‐Voglauer · 2014 · New Biotechnology
  9. Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
    Nicholas J. Veomett, Tao Dao, Hong Liu, Jingyi Xiang, Dmitry Pankov, Leonid Dubrovsky, Joseph A. Whitten, Sun‐Mi Park, Tatyana Korontsvit, Victoria Zakhaleva et al. · 2014 · Clinical Cancer Research
  10. A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer
    Paul D. Ponath, Daniel Lopes De Menezes, Chin Pan, Bing Y. Chen, Miho Oyasu, Debbie C. Strachan, Heidi N. LeBlanc, Huadong Sun, Xi-Tao Wang, Vangipuram S. Rangan et al. · 2018 · Clinical Cancer Research
  11. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC
    Roland Repp, Christian Kellner, Anja Muskulus, Matthias Staudinger, Sahar Mohseni Nodehi, Pia Glorius, Dalia Akramienė, Michael Dechant, Georg H. Fey, Patrick H.C. van Berkel et al. · 2011 · Journal of Immunological Methods
  12. γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay
    Ursula J. E. Seidel, Fabian Vogt, Ludger Große‐Hovest, Gundram Jung, Rupert Handgretinger, Peter Lang · 2014 · Frontiers in Immunology
  13. Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
    Ngoc Phuong Lan Le, Thomas A. Bowden, Weston B. Struwe, Max Crispin · 2016 · Biochimica et Biophysica Acta (BBA) - General Subjects
  14. Model-based analysis of N-glycosylation in Chinese hamster ovary cells
    Frederick J. Krambeck, Sandra V. Bennun, Mikael Rørdam Andersen, Michael J. Betenbaugh · 2017 · PLoS ONE
  15. A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodies
    Joseph Siemiatkoski, Yelena V. Lyubarskaya, Damian J. Houde, Samnang Tep, Rohin Mhatre · 2005 · Carbohydrate Research
  16. Fc Glycans Terminated withN-Acetylglucosamine Residues Increase Antibody Resistance to Papain
    T. Shantha Raju, Bernard J. Scallon · 2007 · Biotechnology Progress
  17. Dual-regulated expression technology: a new era in the adjustment of heterologous gene expression in mammalian cells
    Samuel Moser, Markus Rimann, Cornelia Fux, Stefan Schlatter, James E. Bailey, Martin Fussenegger · 2001 · The Journal of Gene Medicine
  18. Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel
    Shazad Q. Ashraf, Angela M. Nicholls, Jennifer L. Wilding, Triantafyllia G. Ntouroupi, Neil Mortensen, Walter Fred Bodmer · 2012 · Proceedings of the National Academy of Sciences
  19. Biological consequences of overexpressing or eliminating N-acetylglucosaminyltransferase-TIII in the mouse
    Pamela Stanley · 2002 · Biochimica et Biophysica Acta (BBA) - General Subjects
  20. The dynamic behavior of storage organelles in developing cereal seeds and its impact on the production of recombinant proteins
    Elsa Arcalís, Verena Ibl, Jenny Peters, Stanislav Melnik, Eva Stöger · 2014 · Frontiers in Plant Science
  21. A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
    Pina M. Cardarelli, Chetana Rao‐Naik, Sharline Chen, Haichun Huang, Amie Pham, Maria-Cristina Moldovan-Loomis, Chin Pan, Ben Preston, David Passmore, Jie Liu et al. · 2009 · Cancer Immunology Immunotherapy
  22. Controlling the time evolution of mAb N‐linked glycosylation, Part I: Microbioreactor experiments
    Thomas K. Villiger, Anaïs Roulet, Arnaud Périlleux, Matthieu Stettler, Hervé Broly, Massimo Morbidelli, Miroslav Šoóš · 2016 · Biotechnology Progress
  23. Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins
    Adrien Bosseboeuf, Sophie Allain‐Maillet, Nicolas Mennesson, Anne Tallet, Cédric Rossi, Laurent Garderet, Denis Caillot, Philippe Moreau, Éric Piver, François Girodon et al. · 2017 · Frontiers in Immunology
  24. Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MS n
    Dehui Sun, Fanlei Hu, Huanyu Gao, Zhijing Song, Wenchun Xie, Ping Wang, Lianjie Shi, Ke Wang, Yan Li, Chuncui Huang et al. · 2019 · The Analyst
  25. Production of Antibodies in Plants: Approaches and Perspectives
    Ki Sung Ko, Robert Brodzik, Zenon Steplewski · 2009 · Current topics in microbiology and immunology
  26. Glycosylation Variations with Expression Systems and Their Impact on Biological Activity of Therapeutic Immunoglobulins
    T. Shantha Raju · 2003
  27. Genetic engineering approaches to improve posttranslational modification of biopharmaceuticals in different production platforms
    Amann, Thomas, Schmieder, Valerie, Faustrup Kildegaard, Helene, Borth, Nicole, Andersen, Mikael Rørdam · 2019 · Biotechnology and Bioengineering
  28. IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?
    Yannick Kronimus, Richard C. Dodel, Sebastian Peter Galuska, Sascha Neumann · 2018 · Journal of Autoimmunity
  29. Monoclonal and recombinant antibodies, 30 years after …
    Emmanuelle Laffly, Régis Sodoyer · 2006 · Human Antibodies
  30. Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells
    Meital Edri‐Brami, Benyamin Rosental, Dana Hayoun, Michael Welt, Hila Rosen, Itzhak Wirguin, Beatrice Nefussy, Vivian E. Drory, Angel Porgador, Rachel G. Lichtenstein · 2012 · PLoS ONE
  31. Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression system
    Patrick H.C. van Berkel, Jolanda Gerritsen, Edwin van Voskuilen, Gerrard J. Perdok, Tom Vink, Jan G. J. van de Winkel, Paul W.H.I. Parren · 2009 · Biotechnology and Bioengineering
  32. High‐resolution definition of humoral immune response correlates of effective immunity against HIV
    Galit Alter, Karen G. Dowell, Eric P. Brown, Todd J. Suscovich, Anastassia Mikhailova, Alison E. Mahan, Bruce D. Walker, Falk Nimmerjahn, Chris Bailey‐Kellogg, Margaret E. Ackerman · 2018 · Molecular Systems Biology
  33. Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions
    Blondeel, Eric J.M., Aucoin, Marc G. · 2018 · Biotechnology Advances
  34. Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions
    Michelle Kinder, Allison R. Greenplate, Katharine D. Grugan, Keri L. Soring, Katharine Heeringa, Stephen G. McCarthy, Gregory Bannish, Meredith Perpetua, Frank Lynch, Robert E. Jordan et al. · 2013 · Journal of Biological Chemistry
  35. Fc‐engineered EGF‐R antibodies mediate improved antibody‐dependent cellular cytotoxicity (ADCC) against KRAS ‐mutated tumor cells
    Martin Schlaeth, Sven Berger, Stefanie Derer, Katja Klausz, Stefan Lohse, Michael Dechant, Greg A. Lazar, Tanja Schneider‐Merck, Matthias Peipp, Thomas Valerius · 2010 · Cancer Science
  36. Transcriptional Profiling of Gene Expression Changes in a PACE-Transfected CHO DUKX Cell Line Secreting High Levels of rhBMP-2
    Padraig Doolan, Mark W. Melville, Patrick Gammell, Martin S. Sinacore, Paula Meleady, Kevin John McCarthy, Linda Francullo, Mark W. Leonard, Timothy S. Charlebois, MARTIN M. CLYNES · 2008 · Molecular Biotechnology
  37. Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells
    Fabrizio Marcucci, Matteo Bellone, Cristiano Rumio, Angelo Corti · 2013 · mAbs
  38. Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation
    Andrew G. McDonald, Jerrard M. Hayes, Tania Bezak, Sonia Agnieszka Gluchowska, Eoin F. J. Cosgrave, Weston B. Struwe, Corné J.M. Stroop, Han J Kok, Teun van de Laar, Pauline Mary Rudd et al. · 2014 · Journal of Cell Science
  39. Engineering of Yeast Glycoprotein Expression
    Charlot De Wachter, Linde Van Landuyt, Nico Callewaert · 2018 · Advances in biochemical engineering, biotechnology
  40. High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation
    Hsi‐Chang Shih, Ming‐Chu Chang, Chein‐Hung Chen, I‐Lin Tsai, San‐Yuan Wang, Ya-Po Kuo, Chung‐Hsuan Chen, Yu‐Ting Chang · 2019 · Clinical Proteomics
  41. Synthetic glycobiology: exploits in the Golgi compartment
    Jennifer L. Czlapinski, Carolyn Ruth Bertozzi · 2006 · Current Opinion in Chemical Biology
  42. Functional cross‐kingdom conservation of mammalian and moss (Physcomitrella patens) transcription, translation and secretion machineries
    Marc Gitzinger, Juliana Parsons, Ralf Reski A, Martin Fussenegger · 2008 · Plant Biotechnology Journal
  43. The role of antibody glycosylation in autoimmune and alloimmune kidney diseases
    Anaïs Beyze, Christian Larroque, Moglie Le Quintrec · 2024 · Nature Reviews Nephrology
  44. Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza Virus
    Vikram Srivastava, Zheng Yang, Ivan Fan‐Ngai Hung, Jianqing Xu, Bo‐Jian Zheng, Yijun Zhang · 2013 · Journal of Virology
  45. Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases
    Dan Zhang, Bingchao Chen, Yanmin Wang, Peng Xia, Chengyan He, Yujie Liu, Ruiqing Zhang, Mo Zhang, Zhili Li · 2016 · Scientific Reports
  46. An Update of pTRIDENT Multicistronic Expression Vectors: pTRIDENTs Containing Novel Streptogramin-Responsive Promoters
    Samuel Moser, Stefan Schlatter, Cornelia Fux, Markus Rimann, James E. Bailey, Martin Fussenegger · 2000 · Biotechnology Progress
  47. Modulating antibody effector functions by Fc glycoengineering
    Mikel García-Alija, Berre Van Moer, Diego E. Sastre, Tala Azzam, Jonathan J. Du, Beatriz Trastoy, Nico Callewaert, Eric J. Sundberg, Marcelo E. Guerin · 2023 · Biotechnology Advances
  48. Preparation of recombinant vaccines
    Éric Soler, Louis‐Marie Houdebine · 2007 · Biotechnology annual review
  49. A high‐throughput microchip‐based glycan screening assay for antibody cell culture samples
    Jeremy Primack, Gregory C. Flynn, Hai Pan · 2011 · Electrophoresis
  50. Improved production of monoclonal antibodies through oxygen-limited cultivation of glycoengineered yeast
    Marina Berdichevsky, Marc d′Anjou, Muralidhar R. Mallem, Seemab S. Shaikh, Thomas I. Potgieter · 2011 · Journal of Biotechnology
  51. A combinatorial genetic library approach to target heterologous glycosylation enzymes to the endoplasmic reticulum or the Golgi apparatus of Pichia pastoris
    Juergen H. Nett, Terrance A. Stadheim, Huijuan Li, Piotr Bobrowicz, Stephen R. Hamilton, Robert C. Davidson, Byung‐Kwon Choi, Teresa Mitchell, Beata Bobrowicz, Alissa M. Rittenhour et al. · 2010 · Yeast
  52. A variant human IgG1-Fc mediates improved ADCC
    Ross A. Stewart, George Thom, Michaela Levens, Gülin Güler-Gane, Robert Holgate, Pauline Mary Rudd, Carl I. Webster, Lutz Jermutus, John Lund · 2011 · Protein Engineering Design and Selection
  53. High-throughput profiling of nucleotides and nucleotide sugars to evaluate their impact on antibody N-glycosylation
    Thomas K. Villiger, Robert Steinhoff, Marija Ivarsson, Thomas Solacroup, Matthieu Stettler, Hervé Broly, Jasmin Krismer, Martin Pabst, Renato Zenobi, Massimo Morbidelli et al. · 2016 · Journal of Biotechnology
  54. IgG N-glycans
    Si Liu, Xin Liu · 2021 · Advances in clinical chemistry
  55. Glycosylation of Natural and Recombinant Antibody Molecules
    Roy Jefferis · 2005 · Advances in experimental medicine and biology
  56. Engineered anti‐CD20 antibodies with enhanced complement‐activating capacity mediate potent anti‐lymphoma activity
    Akito Natsume, Yukiko Shimizu‐Yokoyama, Mitsuo Satoh, Kenya Shitara, Rinpei Niwa · 2009 · Cancer Science
  57. Change in I g G 1 F c N ‐linked glycosylation in human lung cancer: Age‐ and sex‐related diagnostic potential
    Guoqiang Chen, Yanmin Wang, Xuzhen Qin, Hexiang Li, Yumei Guo, Yanying Wang, Hui Liu, Xiaodong Wang, Gaoguang Song, Fang Li et al. · 2013 · Electrophoresis
  58. Glycoforms of Immunoglobulin G Based Biopharmaceuticals Are Differentially Cleaved by Trypsin Due to the Glycoform Influence on Higher-Order Structure
    David Falck, Bas C. Jansen, Rosina Plomp, Dietmar Reusch, Markus Haberger, Manfred Wuhrer · 2015 · Journal of Proteome Research
  59. Glycoengineering design options for IgG1 in CHO cells using precise gene editing
    Morten Alder Schulz, Weihua Tian, Yang Mao, Julie Van Coillie, Lingbo Sun, Joachim Steen Larsen, Yen‐Hsi Chen, Claus Kristensen, Sergey Y. Vakhrushev, Henrik Clausen et al. · 2018 · Glycobiology
  60. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names
    Ian C. Wilkinson, G Hale · 2022 · mAbs
  61. Mammalian Cell Culture for Biopharmaceutical Production
    Jinyou Zhang · 2014 · ASM Press eBooks
  62. Glycoengineering Chinese hamster ovary cells: a short history
    Donini, Roberto, Haslam, Stuart M., Kontoravdi, Cleo · 2021 · Biochemical Society Transactions
  63. Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials
    Roland Béliard · 2006 · Transfusion Clinique et Biologique
  64. Glycoengineering Approach to Half-Life Extension of Recombinant Biotherapeutics
    Chen Chen, Antony Constantinou, Kerry Ann Chester, Bijal Vyas, Kévin Canis, Stuart M. Haslam, Anne Dell, Agamemnon A. Epenetos, Mahendra P. Deonarain · 2012 · Bioconjugate Chemistry
  65. Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells
    Michael Storcksdieck genannt Bonsmann, Thomas Niezold, Vladimir Temchura, Franco Pissani, Katrin Ehrhardt, Eric P. Brown, Nana Yaw Osei‐Owusu, Drew Hannaman, Hartmut Hengel, Margaret E. Ackerman et al. · 2015 · The Journal of Immunology
  66. An Inflammatory Story: Antibodies in Tuberculosis Comorbidities
    Milla R. McLean, Lenette L. Lu, Stephen John Kent, Amy W. Chung · 2019 · Frontiers in Immunology
  67. Versatile macrolide‐responsive mammalian expression vectors for multiregulated multigene metabolic engineering
    Wilfried Weber, René R. Marty, Bettina Keller, Markus Rimann, Beat P. Kramer, Martin Fussenegger · 2002 · Biotechnology and Bioengineering
  68. Global insights into the Chinese hamster and CHO cell transcriptomes
    Nandita Vishwanathan, Andrew Yongky, Kathryn C. Johnson, Hsu‐Yuan Fu, Nitya M. Jacob, Huong Le, Faraaz N.K. Yusufi, Dong‐Yup Lee, Wei‐Shou Hu · 2014 · Biotechnology and Bioengineering
  69. Recent advances in the analysis of carbohydrates for biomedical use
    Keita Yamada, Kazuaki Kakehi · 2011 · Journal of Pharmaceutical and Biomedical Analysis
  70. Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines
    Yusuke Mimura, Ronan M. Kelly, Louise Unwin, Simone Albrecht, Roy Jefferis, Margaret D Goodall, Yoichi Mizukami, Yuka Mimura‐Kimura, Tsuneo Matsumoto, Hiroshi Ueoka et al. · 2015 · Journal of Immunological Methods
  71. Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies
    Tiezheng Li, Chao Li, David N. Quan, William E. Bentley, Lai‐Xi Wang · 2018 · Carbohydrate Research
  72. Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked Oligosaccharides
    Emi Shoji-Hosaka, Yukari Kobayashi, Masako Wakitani, Kazuhisa Uchida, Rinpei Niwa, Kazuyasu Nakamura, Kenya Shitara · 2006 · The Journal of Biochemistry
  73. In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants
    Vally Kommineni, Matthew Markert, Zhongjie Ren, Sreenath Palle, Berenice Carrillo, Jasmine Deng, Armando Tejeda, Somen Nandi, Karen A. McDonald, Sylvain Marcel et al. · 2019 · International Journal of Molecular Sciences
  74. A Review of Antibody Therapeutics and Antibody-Related Technologies for Oncology
    Bernard J. Scallon, Linda A. Snyder, G. Mark Anderson, Qiming Chen, Yan Li, Louis M. Weiner, Marian T. Nakada · 2006 · Journal of Immunotherapy
  75. Quantitative in vivo comparisons of the Fcγ receptor-dependent agonist activities of different fucosylation variants of an immunoglobulin G antibody
    Bernard J. Scallon, Stephen G. McCarthy, Jennifer Radewonuk, Ann Cai, Michael F. Naso, T. Shantha Raju, Renold J. Capocasale · 2007 · International Immunopharmacology
  76. Diversity in host clone performance within a C hinese hamster ovary cell line
    Peter M. O’Callaghan, Maud E. Berthelot, Robert J. Young, James W.A. Graham, Andrew J. Racher, Dulce Aldana · 2015 · Biotechnology Progress
  77. Centralized Modularity of N-Linked Glycosylation Pathways in Mammalian Cells
    Pan‐Jun Kim, Dong‐Yup Lee, Hawoong Jeong · 2009 · PLoS ONE
  78. Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity
    Kathryn L. Armour, David R. Parry-Jones, N. Beharry, James R. Ballinger, Rosey Mushens, R. Keith Williams, Cynthia Beatty, Simon J. Stanworth, Paul Lloyd-Evans, Marion L. Scott et al. · 2005 · Blood
  79. Biopharmaceutical Proteins: Opportunities and Challenges
    John R. Birch, Emmanuel Onakunle Onabanjo · 2005 · Humana Press eBooks
  80. Genentech's glyco-engineered antibody to succeed Rituxan
    Mark Ratner · 2014 · Nature Biotechnology
  81. EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity
    Stéphane Olivier, Marine Jacoby, Cédric Brillon, Sylvana Bouletreau, Thomas Mollet, Olivier Nerrière, Audrey Angel, Sévérine Danet, Boussad Souttou, Fabienne Guéhenneux et al. · 2010 · mAbs
  82. Partial filling affinity capillary electrophoresis using large-volume sample stacking with an electroosmotic flow pump for sensitive profiling of glycoprotein-derived oligosaccharides
    Eriko Fukushima, Yuki Yagi, Sachio Yamamoto, Yumi Nakatani, Kazuaki Kakehi, Takao Hayakawa, Shigeo Suzuki · 2012 · Journal of Chromatography A
  83. XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
    Juergen M. Schanzer, Katharina Wartha, Ekkehard Moessner, Ralf J. Hosse, Samuel Moser, Rebecca Croasdale, Halina Trochanowska, Cuiying Shao, Peng Wang, Lei Shi et al. · 2016 · mAbs
  84. Engineering novel Lec1 glycosylation mutants in CHO–DUKX cells: Molecular insights and effector modulation of N‐acetylglucosaminyltransferase I
    Xiaotian Zhong, Cecilia Cooley, Nilufer P. Seth, Zong Sean Juo, Ella Presman, Nicole Resendes, Ravi A. Kumar, Martin Allen, Lidia Mosyak, Mark Stahl et al. · 2012 · Biotechnology and Bioengineering
  85. Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and Quantitation
    Justin M. Prien, Henning Stöckmann, Simone Albrecht, Silvia Millán‐Martín, Matthew Varatta, Marsha Furtado, Stephen Hosselet, Meiyao Wang, Trina Formolo, Pauline Mary Rudd et al. · 2015 · ACS symposium series
  86. Glycomodification and characterization of anti-colorectal cancer immunotherapeutic monoclonal antibodies in transgenic tobacco
    Yangkang So, Kyung-Jin Lee, Deuk-Su Kim, Jeong Hwan Lee, Doo‐Byoung Oh, Kyung‐A Hwang, Kinarm Ko, Young‐Kug Choo, Ko Kisung · 2012 · Plant Cell Tissue and Organ Culture (PCTOC)
  87. Short‐hairpin‐RNA‐mediated silencing of fucosyltransferase 8 in Chinese‐hamster ovary cells for the production of antibodies with enhanced antibody immune effector function
    Vincent Beuger, Klaus‐Peter Künkele, Hans Koll, Achim Gärtner, Monika Bähner, Helmut J. BURTSCHER, Christian Klein · 2008 · Biotechnology and Applied Biochemistry
  88. Towards the development of a surface plasmon resonance assay to evaluate the glycosylation pattern of monoclonal antibodies using the extracellular domains of CD16a and CD64
    July Dorion-Thibaudeau, Céline Raymond, Erika Lattová, Hélène Perreault, Yves Durocher, Grégory De Crescenzo · 2014 · Journal of Immunological Methods
  89. The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding Domain
    Luis R Miranda, Mark Duval, Heather Doherty, Michael S. Seaman, Marshall R. Posner, Lisa A. Cavacini · 2007 · The Journal of Immunology
  90. State‐of‐the‐art technologies for rapid and high‐throughput sample preparation and analysis of N‐glycans from antibodies
    Udayanath Aich, Jude C. Lakbub, Aston Liu · 2016 · Electrophoresis
  91. Glycobiology of Aging
    Fabio Dall’Olio · 2018 · Sub-cellular biochemistry/Subcellular biochemistry
  92. Antibody Expression and Production
    Mohamed Al‐Rubeai · 2011 · Cell engineering
  93. Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges
    Jean‐Luc Teillaud · 2005 · Expert Opinion on Biological Therapy
  94. Modulation of translation‐initiation in CHO‐K1 cells by rapamycin‐induced heterodimerization of engineered eIF4G fusion proteins
    Stefan Schlatter, Claudia Senn, Martin Fussenegger · 2003 · Biotechnology and Bioengineering
  95. Modern Antibody Technology: The Impact on Drug Development
    Simon E. Moroney, Andreas Plückthun · 2005 · Wiley eBooks
  96. The Association Between Low Back Pain and Composition of IgG Glycome
    Maxim B. Freidin, Toma Keser, Ivan Gudelj, Jerko Štambuk, Dunja Vučenović, Massimo Allegri, Tamara Štambuk, Mirna Šimurina, Stella M. Fabiane, Gordan Lauc et al. · 2016 · Scientific Reports
  97. Impact of IgG Fc‐Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy
    Hongcheng Liu, Christine Nowak, Bruce A. Andrien, Mei Shao, Gomathinayagam Ponniah, Alyssa Neill · 2017 · Biotechnology Progress
  98. Cell culture media supplementation of uncommonly used sugars sucrose and tagatose for the targeted shifting of protein glycosylation profiles of recombinant protein therapeutics
    Patrick Hossler, Sean McDermott, Christopher Racicot, Christopher Chumsae, Haly Raharimampionona, Yu Zhou, David Ouellette, Joseph G. Matuck, Ivan Correia, John Fann et al. · 2014 · Biotechnology Progress
  99. Glycoprotein biomarkers and analysis in chronic obstructive pulmonary disease and lung cancer with special focus on serum immunoglobulin G
    Andras Komaromy, Balazs Reider, Gábor Járvás, András Guttman · 2020 · Clinica Chimica Acta
  100. OUP accepted manuscript
    Tea Pribić, Inês Alves, Dario Bugada, Julio Pascual, Frano Vučković, Andrea Skelin, Joana Gaifem, Judit Villar-García, Manuel M Vicente, Ângela Fernandes et al. · 2020 · Glycobiology